| Clinical Senior Lecturer in HIV |
Contact details:
| Tel: | +44 20 7882 2316 |
| Fax: | +44 20 7882 2181 |
| Email: | j.deayton@qmul.ac.uk |
| Address: | Centre for Immunology and Infectious Disease, |
Biography:
Dr Jane Deayton qualified from University College and Middlesex Hospital School of Medicine and trained in Genito-urinary and HIV medicine. She gained her PhD in Virology from the Royal Free Hospital, studying CMV in the HIV-infected population. She is an Honorary Consultant Physician in Infection and Immunity at Barts and the London NHS Trust and a member of the British Association of Sexual Health and HIV Herpes Simplex advisory panel.
Research Interests:
Dr Deayton's research interests include opportunistic infections in AIDS, HIV co-infections with Herpes and other viruses and co-factors in HIV disease progression. Other work focuses on the emerging clinical phenomenon of HIV-Associated Neurocognitive Disorder, investigating viral pathogenesis and biomarkers of Central Nervous System inflammation.
Key Publications
• Deayton JR. Is cytomegalovirus viraemia a useful tool in managing CMV disease? Sexually Transmitted Infections 2000;82:342-4
• Deayton JR, Griffiths PD. When can prophylaxis for cytomegalovirus disease be stopped? Curr Opin Infect Dis 2000;13:637-4
• Deayton JR, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC, Griffiths PD. Changes in the natural history of cytomegalovirus retinitis following the introduction of HAART. AIDS 2000;14:1163-70
• Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD. Loss of cytomegalovirus viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. AIDS 1999;13:1203-6
• Gyrzywacz M, Deayton JR, Bowen EF, Wilson P, Tyrer M, Johnson MA, Emery VC, Griffiths PD. Response of asymptomatic CMV viraemia to oral ganciclovir 3g/day or 6g/day. J Med Virol 1999;59:323-328
• Sabin CA, Clewley GS, Deayton JR, Mocroft A, Johnson MA, Lee CA, McLaughlin JE, Griffiths PD. Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract. J Med Virol 1999;58:280-85
• Mocroft A, Sabin C, Youle M, Lipman M, Madge S, Devereux H, Deayton J, Dykhoff A, Tyrer M, Phillips AN, Johnson MA. Changes in AIDS defining illnesses: Royal Free Hospital 1988-1997. JAIDS 1999;21:401-7
